THC And Driving Impairment Duration

Researchers at Australia’s Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney have defined durations of impairment after THC dosing – but it’s not straightforward.
With more people discovering the benefits of medical cannabis, this raises the important issue of potential impairment while driving. In Australia, any detectable amount of tetrahydrocannabinol (THC) in a driver’s bloodstream or saliva is enough to land the person in legal hot water; even if there is no impairment. With THC remaining detectable for up to weeks after ingestion, this effectively puts patients using legally prescribed medicines containing the compound under a driving ban.
Unlike alcohol, there is no clear relationship between blood THC concentrations and impairment given the complex pharmacokinetics of the compound.
“Prosecution solely on the basis of the presence of THC in blood or saliva is manifestly unjust,” said Lambert Initiative Academic Director Professor Iain McGregor.
After analysis of 80 scientific studies, the researchers have concluded there is a ‘window of impairment’ of between three and 10 hours caused by moderate to high doses of THC. Most driving-related skills are predicted to recover within 5 hours (and almost all within 7 hours) of inhaling (smoking, vaporising) 20 mg of THC, but the impacts of THC taken orally (oils, sprays or capsules) will take longer kick in and then to dissipate.
However, the study concludes there appears to be no universal answer to the question of “how long to wait before driving?” following cannabis use given the number of variables involved, including whether a person is a regular or occasional user. It appears regular cannabis users experience less THC-induced impairment than occasional users as they build tolerance, but may dose higher – bringing impairment into line with occasional users.
Still, Professor McGregor says an evidence-based approach to drug-driving laws is needed.
The study has been published in the journal Neuroscience & Biobehavioral Reviews.
On a related note, a study led by the Lambert Initiative last year found consumption of cannabidiol (CBD) doesn’t impair driving ability. Another previous study by the Lambert Initiative compared the effects of THC-dominant and THC/cannabidiol (CBD) equivalent cannabis on simulated driving and cognitive performance.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.